Durusu Murat, Eryilmaz Mehmet, Oztürk Gürkan, Menteş Oner, Ozer Tahir, Deniz Turgut
Department of Emergency Medicine, Diyarbakir Military Hospital, Diyarbakir, Turkey.
Ulus Travma Acil Cerrahi Derg. 2010 May;16(3):191-7.
In this study, we aimed to compare the efficacy of aggressive fluid resuscitation, low-volume fluid resuscitation and permissive hypotensive resuscitation in an experimental uncontrolled hemorrhagic shock model.
Forty-four male Guinea pigs were used in the study in an experimental uncontrolled shock model. Guinea pigs were split into six groups including normovolemic-normotensive fluid treatment group, normovolemic-permissive hypotensive fluid treatment group, low-volume normotensive fluid treatment group, low-volume permissive hypotensive fluid treatment group, no treatment (n=6), and sham-operated groups (n=6). Resuscitation was initiated when mean arterial pressure (MAP) reached 30 mmHg. In the permissive hypotensive resuscitation group, fluid treatment continued until MAP reached 45+/-5 mmHg and in the aggressive fluid groups until MAP reached 60+/-5 mmHg. Resuscitation fluid was hetastarch 6% (hydroxyethyl starch) in the low-volume fluid groups and Ringer's lactate in the normovolemic fluid groups.
Mean survival time was 122.75+/-4.83 min in the normovolemic-normotensive fluid group, 130.87+/-16.31 min in the normovolemic-permissive hypotensive group, 122.12+/-11.53 min in the low-volume-normotensive fluid group, and 152.25+/-9.10 min in the low-volume-permissive hypotensive fluid group. Survival time was found significantly higher in the group in which low-volume-permissive hypotensive fluid treatment was applied than in the other groups.
When pressure effect was compared during treatment, permissive-hypotensive resuscitation was found more effective in both groups that received colloid and crystalloid treatment.
在本研究中,我们旨在比较在实验性非控制性出血性休克模型中积极液体复苏、小容量液体复苏和允许性低血压复苏的疗效。
本研究使用44只雄性豚鼠建立实验性非控制性休克模型。豚鼠被分为六组,包括血容量正常-血压正常液体治疗组、血容量正常-允许性低血压液体治疗组、小容量血压正常液体治疗组、小容量允许性低血压液体治疗组、未治疗组(n = 6)和假手术组(n = 6)。当平均动脉压(MAP)达到30 mmHg时开始复苏。在允许性低血压复苏组中,液体治疗持续至MAP达到45±5 mmHg,在积极液体治疗组中持续至MAP达到60±5 mmHg。小容量液体组的复苏液为6%羟乙基淀粉(贺斯),血容量正常液体组为乳酸林格氏液。
血容量正常-血压正常液体组的平均生存时间为122.75±4.83分钟,血容量正常-允许性低血压组为130.87±16.31分钟,小容量血压正常液体组为122.12±11.53分钟,小容量允许性低血压液体组为152.25±9.10分钟。发现应用小容量允许性低血压液体治疗的组的生存时间显著高于其他组。
在比较治疗期间的压力效应时,发现允许性低血压复苏在接受胶体和晶体治疗的两组中均更有效。